Hong Kong Stock Alert | YIDU TECH (02158) Surges Over 6% as AI Healthcare Business Advances, Recently Wins SMR001 Eye Drops Phase III Clinical Research Project

Stock News

Oct 03

YIDU TECH (02158) surged over 6%, and as of press time, the stock was up 6.27% to HK$7.12, with trading volume reaching HK$112 million.

On the news front, YIDU TECH announced that its affiliated company Tianjin Happy Life Technology Co., Ltd. recently won the bid for Shandong Yandu Biotechnology Co., Ltd.'s recombinant human nerve growth factor (SMR001) eye drops Phase III clinical research project, with a total project value of approximately RMB 55.82 million.

Additionally, the "First Medical Artificial Intelligence Conference and Healthcare Industry AI Application and Industrial Development Exhibition," hosted by the Chinese Journal of Health Informatics, was recently held in Jinan. At the conference's "AI-Driven Medical Quality Improvement" forum, Dr. Li Linfeng, Vice President of Technology Innovation and AI Architect at YIDU TECH, introduced that the company has built a "Doctor Copilot" that deeply integrates with clinical workflows, using "big data + YIDU's vertical domain large model" as its technical foundation.

Currently, the Doctor Copilot has been implemented in multiple hospitals, effectively improving diagnostic and treatment efficiency and quality, helping clinical practice achieve intelligent and standardized upgrades.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1177251048"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1177251048\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1177251048?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-03 14:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1177251048","market":"sh","top_or_hot":-1,"title":"Hong Kong Stock Alert | YIDU TECH (02158) Surges Over 6% as AI Healthcare Business Advances, Recently Wins SMR001 Eye Drops Phase III Clinical Research Project","media":"Stock News","content":"<p>YIDU TECH (02158) surged over 6%, and as of press time, the stock was up 6.27% to HK$7.12, with trading volume reaching HK$112 million.</p>\n<p>On the news front, YIDU TECH announced that its affiliated company Tianjin Happy Life Technology Co., Ltd. recently won the bid for Shandong Yandu Biotechnology Co., Ltd.'s recombinant human nerve growth factor (SMR001) eye drops Phase III clinical research project, with a total project value of approximately RMB 55.82 million.</p>\n<p>Additionally, the \"First Medical Artificial Intelligence Conference and Healthcare Industry AI Application and Industrial Development Exhibition,\" hosted by the Chinese Journal of Health Informatics, was recently held in Jinan. At the conference's \"AI-Driven Medical Quality Improvement\" forum, Dr. Li Linfeng, Vice President of Technology Innovation and AI Architect at YIDU TECH, introduced that the company has built a \"Doctor Copilot\" that deeply integrates with clinical workflows, using \"big data + YIDU's vertical domain large model\" as its technical foundation.</p>\n<p>Currently, the Doctor Copilot has been implemented in multiple hospitals, effectively improving diagnostic and treatment efficiency and quality, helping clinical practice achieve intelligent and standardized upgrades.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong Stock Alert | YIDU TECH (02158) Surges Over 6% as AI Healthcare Business Advances, Recently Wins SMR001 Eye Drops Phase III Clinical Research Project</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong Stock Alert | YIDU TECH (02158) Surges Over 6% as AI Healthcare Business Advances, Recently Wins SMR001 Eye Drops Phase III Clinical Research Project\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-10-03 14:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>YIDU TECH (02158) surged over 6%, and as of press time, the stock was up 6.27% to HK$7.12, with trading volume reaching HK$112 million.</p>\n<p>On the news front, YIDU TECH announced that its affiliated company Tianjin Happy Life Technology Co., Ltd. recently won the bid for Shandong Yandu Biotechnology Co., Ltd.'s recombinant human nerve growth factor (SMR001) eye drops Phase III clinical research project, with a total project value of approximately RMB 55.82 million.</p>\n<p>Additionally, the \"First Medical Artificial Intelligence Conference and Healthcare Industry AI Application and Industrial Development Exhibition,\" hosted by the Chinese Journal of Health Informatics, was recently held in Jinan. At the conference's \"AI-Driven Medical Quality Improvement\" forum, Dr. Li Linfeng, Vice President of Technology Innovation and AI Architect at YIDU TECH, introduced that the company has built a \"Doctor Copilot\" that deeply integrates with clinical workflows, using \"big data + YIDU's vertical domain large model\" as its technical foundation.</p>\n<p>Currently, the Doctor Copilot has been implemented in multiple hospitals, effectively improving diagnostic and treatment efficiency and quality, helping clinical practice achieve intelligent and standardized upgrades.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1518","symbol_name":"SaaS概念","start_time":0,"source_url":"","article_id":"1177251048","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1177251048","pubTimestamp":1759473626,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"YIDU TECH (02158) surged over 6%, and as of press time, the stock was up 6.27% to HK$7.12, with trading volume reaching HK$112 million. On the news front, YIDU TECH announced that its affiliated...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159891":"医疗","BK1518":"SaaS概念","BK4614":"Manus概念股","07226":"南方两倍做多恒科","III":"信息服务","YANG":"三倍做空富时中国ETF-Direxion","02158":"医渡科技","HSCEI":"国企指数","BK1189":"医疗保健技术","BK1617":"AI医疗","BK4134":"信息科技咨询与其它服务"},"translate_title":"港股快讯|AI医疗业务推进医渡科技(02158)大涨超6%近日拿下SMR001滴眼液III期临床研究项目","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159891":1,"02158":1,"07226":1,"HSCEI":1,"III":1,"YANG":1},"content_text":"YIDU TECH (02158) surged over 6%, and as of press time, the stock was up 6.27% to HK$7.12, with trading volume reaching HK$112 million.\nOn the news front, YIDU TECH announced that its affiliated company Tianjin Happy Life Technology Co., Ltd. recently won the bid for Shandong Yandu Biotechnology Co., Ltd.'s recombinant human nerve growth factor (SMR001) eye drops Phase III clinical research project, with a total project value of approximately RMB 55.82 million.\nAdditionally, the \"First Medical Artificial Intelligence Conference and Healthcare Industry AI Application and Industrial Development Exhibition,\" hosted by the Chinese Journal of Health Informatics, was recently held in Jinan. At the conference's \"AI-Driven Medical Quality Improvement\" forum, Dr. Li Linfeng, Vice President of Technology Innovation and AI Architect at YIDU TECH, introduced that the company has built a \"Doctor Copilot\" that deeply integrates with clinical workflows, using \"big data + YIDU's vertical domain large model\" as its technical foundation.\nCurrently, the Doctor Copilot has been implemented in multiple hospitals, effectively improving diagnostic and treatment efficiency and quality, helping clinical practice achieve intelligent and standardized upgrades.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}